| scholarly article | Q13442814 |
| P819 | ADS bibcode | 1991PNAS...88.4761M |
| P356 | DOI | 10.1073/PNAS.88.11.4761 |
| P932 | PMC publication ID | 51746 |
| P698 | PubMed publication ID | 2052556 |
| P5875 | ResearchGate publication ID | 21102585 |
| P2093 | author name string | J L Miller | |
| D Cunningham | |||
| C N Finch | |||
| V A Lyle | |||
| P2860 | cites work | DNA sequencing with chain-terminating inhibitors | Q22066207 |
| Cloning of the alpha chain of human platelet glycoprotein Ib: a transmembrane protein with homology to leucine-rich alpha 2-glycoprotein | Q24596653 | ||
| Sequential tests for the detection of linkage | Q24676543 | ||
| Purification of botrocetin from Bothrops jararaca venom. Analysis of the botrocetin-mediated interaction between von Willebrand factor and the human platelet membrane glycoprotein Ib-IX complex | Q28255295 | ||
| A point mutation is responsible for the acquisition of transforming properties by the T24 human bladder carcinoma oncogene | Q28279136 | ||
| Glycoprotein Ib and glycoprotein IX are fully complexed in the intact platelet membrane | Q28304653 | ||
| Polymorphic DNA region adjacent to the 5' end of the human insulin gene | Q29618325 | ||
| Protein structure and cancer | Q30405142 | ||
| Abnormality of glycoprotein Ib in two cases of "pseudo"-von Willebrand's disease | Q33444527 | ||
| Molecular defects in interactions of platelets with the vessel wall | Q33477754 | ||
| von Willebrand factor binds to platelets and induces aggregation in platelet-type but not type IIB von Willebrand disease | Q33478102 | ||
| Pseudo-von Willebrand's disease. An intrinsic platelet defect with aggregation by unmodified human factor VIII/von Willebrand factor and enhanced adsorption of its high-molecular-weight multimers | Q33481677 | ||
| Human neutrophil elastase modulates platelet function by limited proteolysis of membrane glycoproteins | Q34532149 | ||
| Structure of the human blood platelet membrane glycoprotein Ib alpha gene | Q34556080 | ||
| Structure and function of platelet membrane glycoproteins Ib and V. Effects of leukocyte elastase and other proteases on platelets response to von Willebrand factor and thrombin | Q34562281 | ||
| Mechanism of activation of a human oncogene | Q34708285 | ||
| Detection of single DNA base differences by competitive oligonucleotide priming | Q35222182 | ||
| Biological properties of human c-Ha-ras1 genes mutated at codon 12. | Q42817584 | ||
| Increased platelet sensitivity to ristocetin is predicted by the binding characteristics of a GPIb/IX determinant | Q43544501 | ||
| Isolation and functional characterization of the von Willebrand factor-binding domain located between residues His1-Arg293 of the alpha-chain of glycoprotein Ib. | Q43567942 | ||
| Identification of a site in the alpha chain of platelet glycoprotein Ib that participates in von Willebrand factor binding | Q43643833 | ||
| Point mutation analysis in a mammalian gene: rapid preparation of total RNA, PCR amplification of cDNA, and Taq sequencing by a novel method | Q44538844 | ||
| Programs for pedigree analysis: Mendel, Fisher, and dGene | Q59760870 | ||
| Evidence that an abnormality in the glycoprotein Ib alpha gene is not the cause of abnormal platelet function in a family with classic Bernard-Soulier disease | Q68089845 | ||
| Ristocetin-dependent reconstitution of binding of von Willebrand factor to purified human platelet membrane glycoprotein Ib-IX complex | Q69021307 | ||
| Isolation and characterization of human blood platelet mRNA and construction of a cDNA library in lambda gt11. Confirmation of the platelet derivation by identification of GPIb coding mRNA and cloning of a GPIb coding cDNA insert | Q69763932 | ||
| The von Willebrand factor-binding domain of platelet membrane glycoprotein Ib. Characterization by monoclonal antibodies and partial amino acid sequence analysis of proteolytic fragments | Q70010199 | ||
| Further characterization of platelet-type von Willebrand's disease in Japan | Q70228109 | ||
| Unique interactions of asialo von Willebrand factor with platelets in platelet-type von Willebrand disease | Q70365831 | ||
| Studies on the pathophysiology and treatment of von Willebrand's disease. IV. Mechanism of increased ristocetin-induced platelet aggregation in von Willebrand's disease | Q71535514 | ||
| Platelet-type von Willebrand's disease: characterization of a new bleeding disorder | Q72939306 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 4761-5 | |
| P577 | publication date | 1991-06-01 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Mutation in the gene encoding the alpha chain of platelet glycoprotein Ib in platelet-type von Willebrand disease | |
| P478 | volume | 88 |
| Q33381163 | A case of Bernard-Soulier Syndrome due to a homozygous four bases deletion (TGAG) of GPIbalpha gene: lack of GPIbalpha but absence of bleeding |
| Q37408792 | A network medicine approach to human disease |
| Q41681294 | Acquired von Willebrand disease: concise review of occurrence, diagnosis, pathogenesis, and treatment |
| Q36407260 | Adhesive properties of the isolated amino-terminal domain of platelet glycoprotein Ibalpha in a flow field |
| Q36871645 | Asp330 and Tyr331 in the C-terminal cysteine-rich region of the luteinizing hormone receptor are key residues in hormone-induced receptor activation |
| Q21203026 | Bernard-Soulier syndrome (hemorrhagiparous thrombocytic dystrophy) |
| Q36986074 | Binding of platelet glycoprotein Ibalpha to von Willebrand factor domain A1 stimulates the cleavage of the adjacent domain A2 by ADAMTS13. |
| Q37107472 | Clinical, laboratory and therapeutic aspects of platelet-type von Willebrand disease |
| Q41926876 | Diagnosis and Management of Inherited Platelet Disorders |
| Q40746360 | Diagnosis and management of von Willebrand's syndrome. |
| Q33886251 | Diagnosis of platelet-type von Willebrand disease by flow cytometry |
| Q40335934 | Dynamic force spectroscopy of glycoprotein Ib-IX and von Willebrand factor |
| Q79931774 | Effect of von Willebrand factor on the pharmacokinetics of recombinant human platelet glycoprotein Ibalpha-immunoglobulin G1 chimeric proteins |
| Q33899500 | Expression of the phenotypic abnormality of platelet-type von Willebrand disease in a recombinant glycoprotein Ib alpha fragment |
| Q30482774 | Flow-induced structural transition in the beta-switch region of glycoprotein Ib |
| Q36925330 | Functional analysis of a type IIB von Willebrand disease missense mutation: increased binding of large von Willebrand factor multimers to platelets |
| Q34667787 | Gain-of-function GPIb ELISA assay for VWF activity in the Zimmerman Program for the Molecular and Clinical Biology of VWD. |
| Q28216564 | Genetic abnormalities of Bernard-Soulier syndrome |
| Q93063613 | Genetic classification and confirmation of inherited platelet disorders: current status in Korea |
| Q34097468 | Genome-wide association study of hematological and biochemical traits in a Japanese population |
| Q93138681 | Hyperactive GPIb-von Willebrand factor interaction as cause of thrombocytopenia: altered platelet formation versus clearance |
| Q33387543 | Inherited platelet disorders: thrombocytopenias and thrombocytopathies |
| Q26752148 | Inherited platelet disorders: toward DNA-based diagnosis |
| Q41024567 | Laboratory diagnosis of hemorrhagic and thrombotic disorders. |
| Q33493973 | Low shear stress can initiate von Willebrand factor-dependent platelet aggregation in patients with type IIB and platelet-type von Willebrand disease |
| Q36798217 | Mimotope/anti-mimotope probing of structural relationships in platelet glycoprotein Ib alpha |
| Q36559664 | Platelet dysfunction and a high bone mass phenotype in a murine model of platelet-type von Willebrand disease |
| Q37226752 | Platelet hyperreactivity explains the bleeding abnormality and macrothrombocytopenia in a murine model of sitosterolemia |
| Q40789645 | Platelet type von Willebrand disease and registry report: communication from the SSC of the ISTH. |
| Q36384693 | Platelet-VWF complexes are preferred substrates of ADAMTS13 under fluid shear stress |
| Q33422572 | Progress in understanding the diagnosis and molecular genetics of macrothrombocytopenias |
| Q33405346 | Pseudo (platelet-type) von Willebrand disease in pregnancy: a case report |
| Q72124489 | Structural implications of the substitution of Val for Met at residue 239 in the alpha chain of human platelet glycoprotein Ib |
| Q37346480 | Structure and function of von Willebrand factor: relationship to von Willebrand's disease |
| Q33416741 | Systematic analysis of bleeding phenotype in PT-VWD compared to type 2B VWD using an electronic bleeding questionnaire |
| Q33495977 | Systematic screening for genetic polymorphism in human platelet glycoprotein Ibalpha |
| Q45886683 | The inheritance and molecular genetics of von Willebrand's disease |
| Q34421530 | The molecular biology of von Willebrand disease |
| Q33998293 | Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor |
| Q33560436 | Visualizing the von Willebrand factor/glycoprotein Ib-IX axis with a platelet-type von Willebrand disease mutation |
| Q40997967 | von Willebrand disease in children and adolescents |
| Q26863636 | von Willebrand disease: clinical and laboratory lessons learned from the large von Willebrand disease studies |
| Q33899746 | von Willebrand factor mutation enhancing interaction with platelets in patients with normal multimeric structure |
| Q34666946 | von Willebrand factor-mediated platelet adhesion is critical for deep vein thrombosis in mouse models |
| Q41651628 | von Willebrand factor: biological function and molecular defects |
Search more.